Form 4: Prestige Consumer Healthcare Director D'Arecca Acquires 2,202 Shares of Common Stock

Director James D'Arecca acquired 2,202 shares of Prestige Consumer Healthcare Inc. common stock on August 6, 2024, as part of the director compensation program.

Summary

• On August 6, 2024, James D'Arecca, a director of Prestige Consumer Healthcare Inc., acquired 2,202 shares of common stock.
• The acquisition was part of the Issuer's director compensation program.
• These shares were received as restricted stock units, with the number of units determined by dividing $150,000 by the closing stock price of $68.13 on August 6, 2024.
• The restricted stock units vest on the first anniversary of the grant and will be settled by delivering one share of common stock for each vested unit upon death, separation, or change in control.
• Following the transaction, D'Arecca directly owns 4,497 shares of Prestige Consumer Healthcare Inc.

Sentiment

Score: 7

Explanation: The document indicates a director's continued investment in the company, which is generally viewed positively. The transaction itself is routine and expected as part of the director compensation program.

Positives

• The acquisition reflects D'Arecca's continued investment in Prestige Consumer Healthcare Inc.
• The director compensation program aligns director interests with shareholder value.

Future Outlook

The restricted stock units vest on the first anniversary of the grant and will be settled by delivery to the Reporting Person of one share of common stock of the issuer for each vested restricted stock unit promptly following the earliest of (1) the Reporting Person's death, (ii) the Reporting Person's separation or (iii) change in control.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding insider ownership.
• The director compensation program aligns director interests with shareholder value.

Key Dates